BioRestorative Therapies, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BRTX Nasdaq 2836 www.biorestorative.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioRestorative Therapies, Inc.

BioRestorative Announces Closing of $5.0 Million Public Offering - Feb 13th, 2026 6:30 pm
BioRestorative Announces Pricing of $5.0 Million Public Offering - Feb 11th, 2026 8:30 pm
BioRestorative Announces Positive Outcome from Type B Meeting with FDA - Feb 11th, 2026 5:30 am
BioRestorative Completes Patient Enrollment in Landmark Phase 2 Trial of BRTX-100 for Chronic Lumbar Disc Disease - Feb 10th, 2026 6:00 am
BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc Disease - Nov 17th, 2025 5:00 am
BioRestorative (BRTX) Earnings Call Transcript - Nov 13th, 2025 10:04 am
BioRestorative Therapies Inc (BRTX) Q3 2025 Earnings Call Highlights: Strategic Advancements ... - Nov 12th, 2025 10:01 pm
Biorestorative Therapies, Inc. (BRTX) Reports Q3 Loss, Lags Revenue Estimates - Nov 12th, 2025 4:25 pm
BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 12th, 2025 2:05 pm
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates - Nov 10th, 2025 7:10 am
BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 - Nov 5th, 2025 2:30 pm
BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market - Oct 27th, 2025 5:30 am
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio - Oct 22nd, 2025 7:35 am
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit - Oct 15th, 2025 7:35 am
BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show” - Oct 7th, 2025 7:25 am
BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market - Oct 6th, 2025 12:28 pm
Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year? - Sep 26th, 2025 7:40 am
Are Medical Stocks Lagging Black Diamond Therapeutics (BDTX) This Year? - Aug 18th, 2025 7:40 am
BioRestorative Therapies Inc (BRTX) Q2 2025 Earnings Call Highlights: Revenue Surge Amid ... - Aug 13th, 2025 1:13 am
Biorestorative Therapies, Inc. (BRTX) Reports Q2 Loss, Beats Revenue Estimates - Aug 12th, 2025 4:05 pm